Depression treatment during pregnancy may benefit babies' brain development, randomized trial finds

A randomized controlled trial published in Nature Communications suggests that treating maternal depression during pregnancy can positively influence infant brain development. The study found that infants of treated mothers showed structural brain differences associated with lower negative emotionality.
Why it matters
This provides experimental evidence for the intergenerational benefits of mental health interventions, potentially shifting prenatal care standards.
edited by Sadie Harley , reviewed by Robert Egan
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add to Preferred Sources Credit: Unsplash/CC0 Public Domain Treating depression during pregnancy influences infant brain development and early emotional function, according to new research published in Nature Communications .
In the first randomized controlled trial to demonstrate that a prenatal depression intervention can affect infant brain structure, researchers found that babies whose mothers received psychotherapy for depression during pregnancy showed differences in the development of a brain region involved in emotion and memory. Those brain differences were associated with lower negative emotionality in infancy.
The findings provide some of the strongest evidence to date that maternal mental health during pregnancy can have intergenerational effects on child development.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in